Mark Stanley Berger, Chief Medical Officer at Actinium Pharmaceuticals, Inc. (ATNM), bought 5,000 shares at $1.11 ($6K) on 2017-06-15, disclosed to the SEC on 2017-06-15.
Open-market purchase of $6k ATNM by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.